No Data
No Data
No Data
No Data
No Data
Hepion Ends Phase 2 Study for NASH Drug Due to Cash Restraints
Seeking AlphaApr 19 17:10 ET
Madrigal Announces US Launch of NASH/MASH Drug Rezdiffra
Seeking AlphaApr 9 10:03 ET
Inventiva Is Maintained at Buy by Canaccord Genuity
Inventiva Is Maintained at Buy by Canaccord Genuity
Dow JonesApr 8 07:54 ET
Express News | Canaccord Genuity Maintains Buy on Inventiva, Raises Price Target to $20
Moomoo 24/7Apr 8 07:44 ET
Analysts Offer Insights on Healthcare Companies: Inventiva (IVA), CervoMed (CRVO) and Teladoc (TDOC)
TipRanksApr 8 07:30 ET
Inventiva's Latest Move: Issuing Royalty Certificates That Could Dilute Lanifibranor Earnings
TipRanksApr 4 02:00 ET
No Data
No Data